Enrollment is Complete for Multinational Phase 3 Study for Lennox-Gastaut Syndrome!
Zogenix has just announced that they have not only finished enrollment in their Phase 3 investigation of Fintepla for Lennox-Gastaut Syndrome (LGS), but that the final patient has been randomized…